← Open Payments lookup

NICHOLAS LAZURKA: Open Payments

NPI 1225684202 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,563 in 144 payments from 13 companies in 2025. Trend: 2023 $1,190 · 2024 $1,672 · 2025 $2,563

Food & beverage: $2,452Education: $111
CompanyPaymentsAmount
Alkermes, Inc.28$550
Otsuka America Pharmaceutical, Inc.22$327
Teva Pharmaceuticals USA, Inc.13$318
E.R. Squibb & Sons, L.L.C.17$273
Neurocrine BioSciences, Inc.14$238
Janssen Pharmaceuticals, Inc9$210
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$169
Lundbeck LLC14$166
Axsome Therapeutics, Inc.5$113
ABBVIE INC.4$82

Products named: ARISTADA, REXULTI, COBENFY, INGREZZA, CAPLYTA, ABILIFY ASIMTUFII, INVEGA SUSTENNA, Auvelity.

Industry payments across MI — which companies pay providers there.